Display options
Share it on

Clin J Gastroenterol. 2008 Oct;1(3):105-109. doi: 10.1007/s12328-008-0020-5. Epub 2008 Aug 12.

Rapid progression of Epstein-Barr-virus-positive gastric diffuse large B-cell lymphoma during chemoradiotherapy: a case report.

Clinical journal of gastroenterology

Tomonori Sumida, Yasuhiko Kitadai, Hiroshi Masuda, Kei Shinagawa, Miwako Tanaka, Michiyo Kodama, Tsuyoshi Kuroda, Toru Hiyama, Shinji Tanaka, Hirofumi Nakayama, Masaharu Yoshihara, Tadashi Yoshino, Kazuaki Chayama

Affiliations

  1. Department of Medicine and Molecular Science, Hiroshima University Graduate School of Biomedical Science, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
  2. Department of Medicine and Molecular Science, Hiroshima University Graduate School of Biomedical Science, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. [email protected].
  3. Health Service Center, Hiroshima University, Hiroshima, Japan.
  4. Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
  5. Department of Pathology, Hiroshima University Graduate School of Biomedical Science, Hiroshima, Japan.
  6. Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan.

PMID: 26193647 DOI: 10.1007/s12328-008-0020-5

Abstract

A 61-year-old woman was referred to our hospital with epigastralgia and appetite loss. Barium examination and upper gastrointestinal endoscopy revealed uneven erythematous mucosa with multiple elevated lesions from the gastric fornix to the upper corpus. Abdominal computed tomography showed thickening of the wall of the fornix and swelling of perigastric lymph nodes, but whole-body gallium scintigraphy and bone marrow examination did not indicate further involvement. Biopsy specimens showed diffuse infiltration of large atypical lymphoid cells in which Epstein-Barr virus (EBV) was detected by in situ hybridization. Diffuse large B-cell lymphoma (DLBCL), stage II1, was diagnosed. Combination chemotherapy [cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP)], was given, and this was followed by radiotherapy. Partial remission was achieved by chemotherapy, but the disease progressed rapidly during radiotherapy. Because the reported prognosis of EBV-positive DLBCL is unfavorable, the therapeutic strategy for EBV-positive gastric DLBCL should be considered carefully.

Keywords: Chemoradiotherapy; Diffuse large B-cell lymphoma; Epstein-Barr virus

References

  1. Am J Surg Pathol. 2003 Jan;27(1):16-26 - PubMed
  2. Surgery. 1997 May;121(5):501-5 - PubMed
  3. Blood. 2005 Oct 1;106(7):2444-51 - PubMed
  4. Br J Haematol. 2001 Jun;113(3):814-21 - PubMed
  5. Ann Surg. 2004 Jul;240(1):44-50 - PubMed
  6. N Engl J Med. 1998 Jul 2;339(1):21-6 - PubMed
  7. Cancer Sci. 2007 Sep;98(9):1281-7 - PubMed
  8. Leuk Lymphoma. 2001 May;41(5-6):669-73 - PubMed
  9. Am J Clin Pathol. 2007 Oct;128(4):579-84 - PubMed
  10. Cancer Sci. 2005 Jun;96(6):349-52 - PubMed
  11. Cancer Sci. 2006 Feb;97(2):163-6 - PubMed
  12. Clin Cancer Res. 2002 Jan;8(1):29-34 - PubMed
  13. Eur J Cancer. 1996 Dec;32A(13):2306-11 - PubMed
  14. Br J Haematol. 2000 Oct;111(1):239-46 - PubMed
  15. Ann Oncol. 1997;8 Suppl 1:85-8 - PubMed
  16. Leuk Lymphoma. 1995 Apr;17(3-4):321-6 - PubMed

Publication Types